Healthcare Sales & Marketing Network News: chronic kidney disease

Searching News Database: chronic kidney disease

HSMN NewsFeed - 1 Aug 2024
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
Devices Venture Capital

HSMN NewsFeed - 3 Jan 2024
Vasa Therapeutics Announces Closing of Seed Financing to Advance Novel Therapies for Diseases of Cardiovascular Aging
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 23 Aug 2023
Fresenius Medical Care Announces FDA Clearance of Versi(R)HD with GuideMe Software
Devices FDA

HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Dec 2022
FDA Grants Appeal for Ardelyx's XPHOZAH(R) (tenapanor)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 29 Nov 2022
Regulus Therapeutics Announces Appointments of Industry Veterans, Drs. Rekha Garg and Claire Padgett, to Lead Clinical Development, Regulatory and Clinical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2022
Pathalys Pharma Announces Executive Team Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2021
Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 18 May 2021
Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive Patients
Devices Interventional Cardiology

HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
Devices

HSMN NewsFeed - 26 Aug 2020
Akebia Therapeutics Announces First Commercial Launch of VAFSEO(TM) (vadadustat tablets), a New Oral Treatment for Anemia Due to Chronic Kidney Disease, in Japan
Biopharmaceuticals Product Launch

HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Jun 2020
Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals

HSMN NewsFeed - 5 May 2020
DaVita Launches Venture Group to Accelerate Advancements in Kidney Care
Venture Capital

HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Jan 2020
Monoferric(R) (Ferric Derisomaltose) Injection Is Approved by the US FDA for the Treatment of Iron Deficiency Anemia
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Oct 2019
Fresenius Medical Care Receives FDA Breakthrough Device Designation for New Dialysis System to Prevent Blood Clotting Without the Use of Blood Thinners
Devices FDA

HSMN NewsFeed - 12 Sep 2019
Healthy.io Raises $60 Million in Series C Funding and Receives FDA Clearance for Smartphone-Based Test to Diagnose Chronic Kidney Disease
Diagnostics Venture Capital Personnel FDA

HSMN NewsFeed - 1 Jul 2019
U.S. CPT Code Granted for KidneyIntelX(TM)
Diagnostics Reimbursement

HSMN NewsFeed - 7 Jun 2019
Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology
Diagnostics

HSMN NewsFeed - 2 May 2019
FDA Grants Breakthrough Device Designation to KidneyIntelX(TM)
Diagnostics FDA

HSMN NewsFeed - 26 Apr 2019
Aratana Therapeutics to be Acquired by Elanco Animal Health
Biopharmaceuticals Veterinary Mergers & Acquisitions

HSMN NewsFeed - 14 Jan 2019
ProKidney Announces $62 million Acquisition of inRegen
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 10 Dec 2018
Rockwell Medical, Inc. Appoints New Vice President, Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2018
Rockwell Medical Provides Update on IV Triferic
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Oct 2018
Rockwell Medical Appoints VP, Strategic Accounts
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Aug 2018
Rockwell Medical Appoints New Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2018
A Big Win for Digital Health: U.S. FDA Grants Landmark Class II Approval for Clinical Grade Smartphone Testing - Healthy.io’s Dip.io Urinalysis
Devices Diagnostics FDA

HSMN NewsFeed - 16 Jul 2018
Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories, Inc.
Diagnostics Product Launch

HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
Devices Mergers & Acquisitions

HSMN NewsFeed - 11 Apr 2018
Somatus Raises $11 Million in Series B Financing
Devices Venture Capital

HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 11 Dec 2017
Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2017
AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Mar 2017
New Study Finds Abiomed Impella(R) Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Devices Interventional Cardiology

HSMN NewsFeed - 8 Feb 2017
FDA Approves Amgen's Parsabiv(TM) (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2016
AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Oct 2016
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
Devices Product Launch

HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals

HSMN NewsFeed - 25 Aug 2016
Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Aug 2016
Amgen Provides Update On Status Of Parsabiv(TM) (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 24 Jun 2016
Medigus’ MUSE(TM) Continues to Gain Clinical Adoption in the U.S.
Devices Surgery Gastroenterology

HSMN NewsFeed - 21 Jun 2016
Keryx Biopharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions

HSMN NewsFeed - 29 Jan 2016
Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Nov 2015
CVRx(R) Announces Expedited Access Pathway Designation By FDA for Barostim Therapy(R) for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients
Devices Cardiology FDA

HSMN NewsFeed - 9 Sep 2015
Rockwell Medical Announces the U.S. Commercial Launch of Triferic(TM)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 3 Jun 2015
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 May 2015
Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 26 May 2015
CVRx(R) Barostim Therapy(R) for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference
Devices Cardiology

HSMN NewsFeed - 16 Mar 2015
Astute Medical, Inc. Previews International Intensive Care Meeting
Diagnostics

HSMN NewsFeed - 19 Feb 2015
ZS Pharma Hires Key Medical Affairs and Commercial Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2014
Complexa, Inc. Completes $13 Million Series B Financing to Further Advance Clinical Development of CXA-10
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 May 2014
Proteon Therapeutics Announces $45 Million of Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 May 2014
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 5 May 2014
FDA Approves Conversion of Soliris(R) (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 21 Jan 2014
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2014
Shield Therapeutics' ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 Oct 2013
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2013
Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to India
Devices

HSMN NewsFeed - 26 Sep 2013
Relypsa Adds Renal Industry Veteran John P. Butler to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jul 2013
La Jolla Pharmaceutical Company Receives Orphan Designation From FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 Jul 2013
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2013
Rockwell Medical Receives $20 Million in New Financing
Biopharmaceuticals

HSMN NewsFeed - 13 Mar 2013
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2013
CorMedix Signs Sales and Marketing Agreement with MKM Co-Pharma, Bolsters Commercial Management Team to Ready Neutrolin(R) Catheter Lock Solution for European Market
Biopharmaceuticals Devices Distribution

HSMN NewsFeed - 14 Jan 2013
La Jolla Pharmaceutical Company Adds to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2013
AWAK Technologies Enters into an Exclusive Agreement with Baxter International for the Development of Wearable Dialysis Technology
Devices

HSMN NewsFeed - 5 Dec 2012
Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2012
Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro
Devices Mergers & Acquisitions

HSMN NewsFeed - 8 Nov 2012
FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System
Diagnostics FDA

HSMN NewsFeed - 7 Nov 2012
John A. Orwin Joins Array BioPharma Board Of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Oct 2012
Tengion Provides Patient Update on its Neo-Urinary Conduit(TM) Clinical Program
Devices Urology

HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 Apr 2012
Amgen to Acquire Privately Held KAI Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Feb 2012
Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity(TM) 1 Renal Denervation System across Multiple Conditions
Devices Cardiology

HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 19 Oct 2011
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Biopharmaceuticals Devices Diagnostics

HSMN NewsFeed - 29 Sep 2011
CorMedix Announces FDA Designation for Neutrolin (CRMD003)
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2011
Thrasos Appoints Dr. Andreas Orfanos as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2011
KAI Pharmaceuticals Signs Agreement for Development and Commercialization of KAI-4169 in Japan with Ono Pharmaceutical
Biopharmaceuticals

HSMN NewsFeed - 12 Sep 2011
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2011
Tengion Announces Leadership Transition
Regenerative Medicine Personnel

HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 23 Jun 2011
CorMedix Provides Regulatory Update For CRMD003 (Neutrolin(R))
Devices

HSMN NewsFeed - 13 Jun 2011
Cytochroma Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2011
CorMedix Appoints Mark A. Klausner, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2011
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
Devices Interventional Cardiology

HSMN NewsFeed - 14 Feb 2011
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 11 Jan 2011
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Jul 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2010
Ardian(R) Demonstrates 2-Year Durability of Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
Devices Cardiology

HSMN NewsFeed - 16 Jun 2010
Relypsa Appoints Claire J. Lockey Vice President, Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2010
Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2010
Teva Announces Tentative Approval of Generic Sensipar(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 31 Mar 2010
Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury
Diagnostics FDA

HSMN NewsFeed - 17 Dec 2009
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Nov 2009
Cytochroma Announces Appointment of Peter Moldt to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Oct 2009
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2009
Ardian(R) Demonstrates Durable Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
Devices Cardiology

HSMN NewsFeed - 11 Sep 2009
PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009
Devices Interventional Cardiology

HSMN NewsFeed - 30 Jun 2009
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Mar 2009
Dialysis is Changing: New Treatment Options Offer Patients Greater Flexibility and Control over Lifestyle
Devices

HSMN NewsFeed - 23 Mar 2009
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Devices Cardiology Venture Capital

HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Mar 2009
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Diagnostics Acquisitions

HSMN NewsFeed - 27 Nov 2008
SORIN GROUP EXECUTES AGREEMENT TO ACQUIRE ENDOSCOPIC VESSEL HARVESTING BUSINESS FROM DATASCOPE, INC.
Devices Cardiology Acquisitions

HSMN NewsFeed - 27 Nov 2008
SORIN GROUP ANNOUNCES EUROPEAN MARKET RELEASE AND FIRST IMPLANT OF NEW-GENERATION CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Devices Cardiology

HSMN NewsFeed - 22 Sep 2008
Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 16 Sep 2008
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Sep 2008
Sorin Group Announces the Publication of Superior 21 Year Durability Data with the Mitroflow Valve in Peer-Reviewed Medical Journal
Devices Cardiology

HSMN NewsFeed - 12 Sep 2008
Sorin Group Announces First Successful Uses of New Pediatric Oxygenator and Arterial Filter at Children's Medical Center Dallas
Devices Cardiology

HSMN NewsFeed - 6 Aug 2008
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Jun 2008
HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
Diagnostics

HSMN NewsFeed - 11 Jun 2008
Sorin Group Announces Divestiture of Its Peripheral Stent Business to Datascope
Devices Interventional Acquisitions

HSMN NewsFeed - 19 May 2008
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2008
Sorin Group Announces FDA Approval of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator: OVATIO(TM) CRT
Devices Cardiology FDA

HSMN NewsFeed - 28 Apr 2008
Sorin Group Cardiac Rhythm Management Announces CE Mark and First Implant of a New-Generation CRT-D Device Designed to Provide Hemodynamic Management of Heart Failure
Devices Cardiology Regulatory

HSMN NewsFeed - 21 Apr 2008
Sorin Group Receives Approval to Market S5 Heart-Lung Machine in Japan and Announces Landmark Shipment of 7000th Heart-Lung Machine
Devices Cardiology Regulatory

HSMN NewsFeed - 21 Apr 2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Mar 2008
Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Mar 2008
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2008
Sorin Group Announces FDA Approval of New Defibrillation Leads Range: ISOLINE(TM)
Devices FDA

HSMN NewsFeed - 6 Mar 2008
Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
Biopharmaceuticals

HSMN NewsFeed - 25 Feb 2008
Diazyme Introduces New Test for the Early Detection of Kidney Disease
Diagnostics FDA

HSMN NewsFeed - 15 Feb 2008
Sorin Group Announces U.S. Clinical Trial of Memo 3D(TM) Semirigid Annuloplasty Ring
Devices Cardiology

HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Biopharmaceuticals

HSMN NewsFeed - 28 Dec 2007
Curis, Inc. Announces Sale of its BMP-7 Assets to Stryker Corporation
Biopharmaceuticals Devices Orthopaedic Acquisitions

HSMN NewsFeed - 13 Dec 2007
AMAG Pharmaceuticals, Inc. Announces Update on Sinerem(TM) in Europe
Biopharmaceuticals Radiology Regulatory

HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2007
Sorin Group Announces First U.S. Implant of Mitroflow Aortic Pericardial Heart Valve
Devices Cardiology

HSMN NewsFeed - 4 Dec 2007
Sorin Group Cardiac Rhythm Management Announces the First U.S. Enrollment in the Option Study
Devices Cardiology

HSMN NewsFeed - 9 Nov 2007
HealthTrust Purchasing Group and Bracco Diagnostics Inc. Sign Three-Year Agreement for X-Ray Contrast Media
Biopharmaceuticals Radiology Group Purchasing

HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Biopharmaceuticals

HSMN NewsFeed - 5 Nov 2007
Post-Stroke Patients Treated with Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function
Biopharmaceuticals Cardiology

HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Oct 2007
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Oct 2007
Sorin Group: Announces U.S. FDA's Approval to Market Its Mitroflow Aortic Pericardial Heart Valve in the United States
Devices Cardiology FDA

HSMN NewsFeed - 23 Oct 2007
Roche Considering Legal Options In Patent Litigation Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 22 Oct 2007
FDA Approves Genzyme's Renvela(TM) for Dialysis Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Oct 2007
Sorin Group Announces the First U.S. Clinical Implant of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator - OVATIO(TM) CRT
Devices Cardiology

HSMN NewsFeed - 19 Oct 2007
Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
Biopharmaceuticals

HSMN NewsFeed - 16 Oct 2007
FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia
Biopharmaceuticals

HSMN NewsFeed - 16 Oct 2007
Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2007
Sorin Group Announces the Appointment of Fred Hrkac as President Cardiac Rhythm Management Business Unit
Devices Cardiology Personnel

HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Sep 2007
Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2007
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Sep 2007
SORIN GROUP: Announces U.S. FDA'S Authorization to Market Its Memo 3D(TM) Annuloplasty Ring in the United States
Devices Cardiology FDA

HSMN NewsFeed - 21 Sep 2007
SORIN GROUP: Andre-Michel Ballester Appointed Chief Executive Officer
Devices Cardiology Personnel

HSMN NewsFeed - 13 Sep 2007
Sorin Group: Celebrates 30 Years of Clinical Use of Its Heart Valves and Highlights Activities at EACTS 2007
Devices Cardiology

HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 31 Aug 2007
Sorin Group Launches World's Smallest Implantable Cardioverter Defibrillators in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 29 Aug 2007
FlowMedica Announces Completion of the Benephit System Renal Infusion Therapy (Be-RITe) Registry
Devices

HSMN NewsFeed - 23 Aug 2007
Cytochroma announces appointment of Gordon Ngan, CFA, MBA as Executive Director, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2007
Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical & Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2007
Sorin Group: ELA Medical, Inc. Enrolls First Patient in the NATURE Observational Study in the U.S.
Devices Cardiology

HSMN NewsFeed - 6 Aug 2007
AMAG Pharmaceuticals, Inc. Announces Appointment of Lee F. Allen, M.D., Ph.D. as Chief Medical Officer and Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2007
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
Devices Personnel

HSMN NewsFeed - 27 Jun 2007
Sorin Group and Japan Lifeline Sign Ten-Year Cardiac Rhythm Management (CRM) Partnership Agreement to Boost Market Share in Japan
Devices Cardiology Distribution

HSMN NewsFeed - 13 Jun 2007
Affymax(R) Announces Resignation of Elizabeth A. Czerepak From its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 May 2007
Sorin Group: The Board of Directors Appoints a New Executive Committee
Devices Cardiology Personnel

HSMN NewsFeed - 21 May 2007
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 11 May 2007
The Sorin Group Announces Release of 2007 Cardiac Rhythm Management (CRM) Product Performance Report
Devices Cardiology

HSMN NewsFeed - 9 May 2007
The Sorin Group Announces European Market Release of REPLY(TM), the World's Smallest Pacemaker
Devices Cardiology

HSMN NewsFeed - 3 May 2007
Sorin Group and Mayo Clinic Sign Three-Year Research Agreement for Less Invasive Aortic Heart-Valve Implant
Devices Cardiology Surgery

HSMN NewsFeed - 1 May 2007
Ilypsa Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2007
Osprey Pharmaceuticals Limited Appoints Jack M. Anthony to the Newly Created Position of Senior Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2007
Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
Biopharmacetuicals

HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
GTx Announces Ostarine(TM) Improved Insulin Resistance among Elderly Patients in a Recently Completed Phase II Clinical Trial
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 Apr 2007
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2007
Whole Blood Viscosity to Be Employed for Complications of Type II Diabetes
Devices Cardiology Endocrinology

HSMN NewsFeed - 12 Apr 2007
Data Analyses Outline Efficacy and Safety of MIRCERA(TM) for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 12 Apr 2007
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
Biopharmaceuticals

HSMN NewsFeed - 11 Apr 2007
Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2007
Advanced Magnetics Announces Appointment of David Arkowitz as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2007
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2007
Sorin Group Names Dick Ames Senior Vice President For U.S. Cardiac Rhythm Management
Devices Cardiology Personnel

HSMN NewsFeed - 27 Mar 2007
Corum Medical Signs Licensing Agreement with Brown University and Rhode Island Hospital
Devices Monitoring Licensing

HSMN NewsFeed - 19 Mar 2007
Advanced Magnetics Completes Enrollment in Final Planned Phase III Study of Ferumoxytol as an IV Iron Replacement Therapeutic
Biopharmaceuticals

HSMN NewsFeed - 15 Mar 2007
The Medicines Company Products Angiomax(R) (bivalirudin) and Cleviprex(TM) (clevidipine) Featured in Three Late Breaking Trials at American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Mar 2007
Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2007
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Mar 2007
UK Launch Expands Global Reach of FOSRENOL(R)
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2007
Advanced Magnetics' Ferumoxytol Data Monitoring Committee Identifies No Safety Concerns in Final Data Review
Biopharmaceuticals

HSMN NewsFeed - 1 Mar 2007
The Sorin Group Announces CE Mark and First Implants of Advanced, Next-Generation Pacemakers in Europe
Devices Regulatory Cardiology

HSMN NewsFeed - 23 Feb 2007
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Feb 2007
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
Biopharmaceuticals Radiology Licensing Litigation

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Establish a Joint Research Program in Europe
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2007
Osprey Pharmaceuticals Limited Secures US $9 Million in Financing, Including $3 Million in Venture Debt From MMV Financial, Inc.
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Jan 2007
Sorin Group: CarboMedics Sues ATS Medical for Breach of Contract
Devices Cardiology Licensing Litigation

HSMN NewsFeed - 22 Jan 2007
Sorin Group Announces Successful First Human Implant of Uniquely-Designed Heart Valve Suitable for Percutaneous Procedures
Devices Cardiology

HSMN NewsFeed - 22 Jan 2007
Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Jan 2007
Cytochroma Inc. Announces Completion of $21 Million Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Dec 2006
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Dec 2006
Roche Offers the FDA Additional MIRCERA(R) Data
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2006
Ilypsa Announces Promotion of Gerrit Klaerner, Ph.D. to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2006
Sorin Group Enters into an Exclusive Agreement with Datascope to Distribute Sorin's Peripheral Stent Line
Devices Interventional Distribution

HSMN NewsFeed - 11 Dec 2006
Datascope Announces Exclusive Agreement to Distribute Peripheral Stent Line of Sorin Group
Devices Interventional Distribution

HSMN NewsFeed - 8 Dec 2006
Majority of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Sorin Group: ELA Medical, Inc. Files PMA Submission for Ovatio(TM) CRT
Devices Cardiology FDA

HSMN NewsFeed - 4 Dec 2006
Advanced Magnetics, Inc. Announces Appointment of Timothy G. Healey as Senior Vice President of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Nov 2006
C.E.R.A. Administered Up to Once Every Four Weeks Maintained Stable Hemoglobin Levels in Dialysis Patients with Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2006
Majority of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT(R) (Epoetin alfa) Therapy Initiated Every Two Weeks
Biopharmaceuticals

HSMN NewsFeed - 17 Nov 2006
FOSRENOL(R) Data Show Evidence of Trends Towards Improved Bone Formation in CKD Stage 5 Patients, New Data Presented at ASN Meeting
Biopharmaceuticals

HSMN NewsFeed - 17 Nov 2006
Advanced Magnetics Announces Positive Results from Phase III Study of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2006
Intensive Lipitor Therapy Reduced Heart Attack and Stroke By One-Third In Patients With Chronic Kidney Disease, New Analysis Shows
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Nov 2006
Sorin Group Initiates Multi-Center 'OPTION' Study in Europe
Devices Cardiology

HSMN NewsFeed - 31 Oct 2006
The Latest Head-to-Head Clinical Study Comparing the Risk of CIN between Two Contrast Agents Used in CE-MDCT Examinations Was Published in Investigative Radiology
Biopharmaceuticals Radiology

HSMN NewsFeed - 26 Oct 2006
Ilypsa Announces Appointment of William D. Waddill as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2006
Millennium and Ortho Biotech Enter into U.S. Co-Promotion Agreement for VELCADE(R)(bortezomib) for Injection
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Oct 2006
Study Evaluates Real-World Dosing and Cost Considerations for PROCRIT(R) (Epoetin Alfa) and Darbepoetin Alfa in the Inpatient Hospital Setting
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2006
Affymax Appoints Grace U. Shin as Vice President of Legal Affairs and Corporate Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Oct 2006
U.S. Court Begins Discovery Phase in Patent Infringement Suit
Biopharmaceuticals Litigation

HSMN NewsFeed - 19 Oct 2006
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
Biopharmaceuticals

HSMN NewsFeed - 16 Oct 2006
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
Biopharmaceuticals

HSMN NewsFeed - 13 Oct 2006
Amgen Receives Complete Response Letter for Extended Dosing of Aranesp(R) for Patients with Chronic Kidney Disease and Anemia
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Oct 2006
Affymax Appoints Daniel K. Spiegelman to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2006
Sorin Group Expands Its Presence in the Japanese Market by Introducing Advanced Defibrillation Therapy
Devices Cardiology

HSMN NewsFeed - 19 Sep 2006
Sorin Group's Annuloplasty Ring MEMO 3D(TM) Obtained CE Mark
Devices Cardiology Regulatory

HSMN NewsFeed - 18 Sep 2006
Sorin Group Announces the Preliminary Results of a Multicentric Clinical Trial on Freedom Solo(TM)
Devices Cardiology

HSMN NewsFeed - 11 Sep 2006
Advanced Magnetics Announces the Appointments of Louis Brenner, MD as Senior Vice President and Mohammed A. Salem, PhD as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2006
Amgen Launches Aranesp(R) (Darbepoetin Alfa) Prefilled SureClick(TM) Autoinjector for Treatment of Anemia Associated with Chemotherapy and Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2006
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Jul 2006
C.E.R.A. Anti-Anemia Drug Maintained Stable Hemoglobin Levels in Dialysis Patients With Up to Once Every Four Week Dosing in Phase III Clinical Studies
Biopharmaceuticals

HSMN NewsFeed - 16 Jul 2006
Amgen Announces EVOLVE Trial(TM) To Investigate Impact of Sensipar(R)/Mimpara(R) (cinacalcet HCl) on Mortality and Cardiovascular Morbidity in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease Receiving Dialysis
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Affymax Appoints Kay Slocum as Senior Vice President of Human Resources
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2006
Sorin Group: Six Month Clinical Results of e-Janus Registry
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2006
Large Head-to-Head Study of Aranesp(R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published in the Journal of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 May 2006
Sorin Group Announces FDA Approval of World's Smallest Implantable Cardioverter Defibrillator; OVATIO(TM) Offers Advanced Pacing and Defibrillation Technology to Patients at Risk for Sudden Cardiac Arrest
Devices Cardiology FDA

HSMN NewsFeed - 20 Feb 2006
Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile and Clinical Efficacy in "Real-World" Patients, Particularly in Those With Acute Myocardial Infarction
Devices Interventional Cardiology

Return to NewsFeed

Additional items found! 129

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 129 additional stories matching:
chronic kidney disease
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.